President Trump signs an Executive Order to reschedule marijuana, paving the way for improved research and access to medical marijuana and CBD products for patients and doctors.
In a groundbreaking decision, President Trump is poised to sign an executive order reclassifying marijuana to Schedule III, easing federal restrictions and paving the way for vital medical research. This move aims to benefit Americans suffering from chronic pain and other conditions.
Could cannabis be the key to alleviating chronic back pain? New European trials show promising results, challenging the opioid approach. Discover what experts are saying about this groundbreaking research!
In a surprising move, Texas Governor Greg Abbott vetoed a bill that would have banned all THC consumables, allowing the thriving market of THC-infused products to continue flourishing in the state. This decision protects jobs and revenue while highlighting ongoing debates about marijuana regulation.
Marijuana use among U.S. adults aged 65 and older has surged to a record 7%, highlighting a significant demographic shift. This increase raises health concerns as usage rises among those with chronic illnesses. Discover the latest insights from NYU's research.